Sino Biopharmaceutical Limited

SEHK:1177 Stock Report

Market Cap: HK$59.0b

Sino Biopharmaceutical Dividends and Buybacks

Dividend criteria checks 3/6

Sino Biopharmaceutical is a dividend paying company with a current yield of 1.78% that is well covered by earnings.

Key information

1.8%

Dividend yield

0.9%

Buyback Yield

Total Shareholder Yield2.7%
Future Dividend Yield2.8%
Dividend Growth14.2%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareHK$0.060
Payout ratio47%

Recent dividend and buyback updates

Recent updates

Is Sino Biopharmaceutical (HKG:1177) A Risky Investment?

Dec 08
Is Sino Biopharmaceutical (HKG:1177) A Risky Investment?

After Leaping 27% Sino Biopharmaceutical Limited (HKG:1177) Shares Are Not Flying Under The Radar

Oct 02
After Leaping 27% Sino Biopharmaceutical Limited (HKG:1177) Shares Are Not Flying Under The Radar

Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly

Sep 02
Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly

Are Investors Undervaluing Sino Biopharmaceutical Limited (HKG:1177) By 48%?

Jul 12
Are Investors Undervaluing Sino Biopharmaceutical Limited (HKG:1177) By 48%?

Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly

May 21
Here's Why Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt Responsibly

Sino Biopharmaceutical Limited's (HKG:1177) 27% Cheaper Price Remains In Tune With Earnings

Apr 21
Sino Biopharmaceutical Limited's (HKG:1177) 27% Cheaper Price Remains In Tune With Earnings

What Does The Future Hold For Sino Biopharmaceutical Limited (HKG:1177)? These Analysts Have Been Cutting Their Estimates

Apr 03
What Does The Future Hold For Sino Biopharmaceutical Limited (HKG:1177)? These Analysts Have Been Cutting Their Estimates

Sino Biopharmaceutical Limited's (HKG:1177) Intrinsic Value Is Potentially 34% Above Its Share Price

Mar 20
Sino Biopharmaceutical Limited's (HKG:1177) Intrinsic Value Is Potentially 34% Above Its Share Price

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 1177's dividend payments have been volatile in the past 10 years.

Growing Dividend: 1177's dividend payments have increased over the past 10 years.

Dividend Yield vs Market

Sino Biopharmaceutical Dividend Yield vs Market
How does 1177 dividend yield compare to the market?
SegmentDividend Yield
Company (1177)1.8%
Market Bottom 25% (HK)3.2%
Market Top 25% (HK)8.0%
Industry Average (Pharmaceuticals)3.7%
Analyst forecast (1177) (up to 3 years)2.8%

Notable Dividend: 1177's dividend (1.78%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.23%).

High Dividend: 1177's dividend (1.78%) is low compared to the top 25% of dividend payers in the Hong Kong market (8%).

Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (47.2%), 1177's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (18.4%), 1177's dividend payments are well covered by cash flows.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 01:52
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sino Biopharmaceutical Limited is covered by 51 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Justin LiuBNP Paribas Securities (Asia)
Ling ZhangBNP Paribas Securities (Asia)
Wai Chak YuenBOCI Research Ltd.